| Durvalumab plus platinum–etoposide versus platinum–etoposide in first-line treatment of extensive-stage small-cell lung cancer (CASPIAN): a randomised, controlled, open-label … L Paz-Ares, M Dvorkin, Y Chen, N Reinmuth, K Hotta, D Trukhin, ... The Lancet 394 (10212), 1929-1939, 2019 | 1515 | 2019 |
| Durvalumab, with or without tremelimumab, plus platinum–etoposide versus platinum–etoposide alone in first-line treatment of extensive-stage small-cell lung cancer (CASPIAN … JW Goldman, M Dvorkin, Y Chen, N Reinmuth, K Hotta, D Trukhin, ... The Lancet Oncology 22 (1), 51-65, 2021 | 423 | 2021 |
| Differentially expressed microRNAs in small cell lung cancer E Miko, Z Czimmerer, E Csánky, G Boros, J Buslig, B Dezső, B Scholtz Experimental lung research 35 (8), 646-664, 2009 | 152 | 2009 |
| Biomarkers of extracellular matrix turnover in patients with idiopathic pulmonary fibrosis given nintedanib (INMARK study): a randomised, placebo-controlled study TM Maher, S Stowasser, Y Nishioka, ES White, V Cottin, I Noth, M Selman, ... The Lancet respiratory medicine 7 (9), 771-779, 2019 | 77 | 2019 |
| Talactoferrin alfa versus placebo in patients with refractory advanced non-small-cell lung cancer (FORTIS-M trial) S Ramalingam, J Crawford, A Chang, C Manegold, R Perez-Soler, ... Annals of oncology 24 (11), 2875-2880, 2013 | 65 | 2013 |
| Discovery of lung cancer biomarkers by profiling the plasma proteome with monoclonal antibody libraries M Guergova-Kuras, I Kurucz, W Hempel, N Tardieu, J Kadas, ... Molecular & Cellular Proteomics 10 (12), 2011 | 62 | 2011 |
| Genetic polymorphism of the human tumor necrosis factor region in insulin-dependent diabetes mellitus linkage disequilibrium of TNFab microsatellite alleles with HLA haplotypes DS Monos, M Kamoun, IA Udalova, E Csanky, B Cizman, RL Turetskaya, ... Human immunology 44 (2), 70-79, 1995 | 62 | 1995 |
| Chronic obstructive pulmonary disease-specific gene expression signatures of alveolar macrophages as well as peripheral blood monocytes overlap and correlate with lung function S Poliska, E Csanky, A Szanto, I Szatmari, B Mesko, L Szeles, B Dezso, ... Respiration 81 (6), 499-510, 2011 | 51 | 2011 |
| Liquid phase separation methods for N-glycosylation analysis of glycoproteins of biomedical and biopharmaceutical interest. A critical review L Hajba, E Csanky, A Guttman Analytica Chimica Acta 943, 8-16, 2016 | 46 | 2016 |
| Restriction Enzyme Analysis of Ribosomal DNA Shows that Candida inconspicua Clinical Isolates Can Be Misidentified as Candida norvegensis with Traditional … L Majoros, G Kardos, A Belak, A Maráz, L Asztalos, E Csánky, Z Barta, ... Journal of Clinical Microbiology 41 (11), 5250-5253, 2003 | 40 | 2003 |
| Analyses of association between PPAR gamma and EPHX1 polymorphisms and susceptibility to COPD in a Hungarian cohort, a case-control study A Penyige, S Poliska, E Csanky, B Scholtz, B Dezso, I Schmelczer, I Kilty, ... BMC medical genetics 11, 1-9, 2010 | 31 | 2010 |
| Comparative analysis of the human serum N-glycome in lung cancer, COPD and their comorbidity using capillary electrophoresis B Mészáros, G Járvás, A Farkas, M Szigeti, Z Kovács, R Kun, M Szabó, ... Journal of Chromatography B 1137, 121913, 2020 | 27 | 2020 |
| Ziritaxestat, a novel autotaxin inhibitor, and lung function in idiopathic pulmonary fibrosis: the ISABELA 1 and 2 randomized clinical trials TM Maher, P Ford, KK Brown, U Costabel, V Cottin, SK Danoff, ... Jama 329 (18), 1567-1578, 2023 | 26 | 2023 |
| Capillary electrophoresis analysis of N‐glycosylation changes of serum paraproteins in multiple myeloma Z Kovacs, A Simon, Z Szabo, Z Nagy, L Varoczy, I Pal, E Csanky, ... Electrophoresis 38 (17), 2115-2123, 2017 | 26 | 2017 |
| Monoclonal antibody proteomics: discovery and prevalidation of chronic obstructive pulmonary disease biomarkers in a single step E Csanky, P Olivova, E Rajnavolgyi, W Hempel, N Tardieu, ET Katalin, ... Electrophoresis 28 (23), 4401-4406, 2007 | 25 | 2007 |
| Glycosylation of random IgG distinguishes seropositive and seronegative rheumatoid arthritis I Magorivska, B Döncző, T Dumych, A Karmash, M Boichuk, K Hychka, ... Autoimmunity 51 (3), 111-117, 2018 | 15 | 2018 |
| High throughput multiplex SNP-analysis in chronic obstructive pulmonary disease and lung cancer Z Elek, Z Kovács, G Keszler, M Szabó, E Csanky, J Luo, A Guttman, ... Current Molecular Medicine 20 (3), 185-193, 2020 | 11 | 2020 |
| Molecular glycopathology by capillary electrophoresis: Analysis of the N‐glycome of formalin‐fixed paraffin‐embedded mouse tissue samples B Donczo, M Szarka, J Tovari, G Ostoros, E Csanky, A Guttman Electrophoresis 38 (12), 1602-1608, 2017 | 10 | 2017 |
| N-glycosylation structure–function characterization of omalizumab, an anti-asthma biotherapeutic product M Szabo, C Filep, M Nagy, D Sarkozy, M Szigeti, E Sperling, E Csanky, ... Journal of Pharmaceutical and Biomedical Analysis 209, 114483, 2022 | 8 | 2022 |
| Machine Learning Based Analysis of Human Serum N-glycome Alterations to Follow up Lung Tumor Surgery B Mészáros, G Járvás, R Kun, M Szabó, E Csánky, J Abonyi, A Guttman Cancers 12 (12), 3700, 2020 | 7 | 2020 |
